Lonza
Cameron Webb, PhD, is a Principal Scientist in LNP Process Development at Lonza since April 2023, specializing in scalable lipid nanoparticle processes for various genetic payloads. Prior experience includes working as a Clinical Scientist Manager at Pfizer, contributing to vaccine development for COVID-19 and other diseases, and serving as a Project Manager and PhD Researcher at the University of Strathclyde. Additionally, Cameron has worked as a locum pharmacist, providing support across multiple health boards during the COVID-19 pandemic. Cameron holds a PhD in Pharmaceutical Sciences and a Master of Pharmacy from the University of Strathclyde.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.